天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

化合物 CI-1040,CI-1040

化合物 CI-1040|T2443|TargetMol

價格 198 443 745
包裝 1mg 5mg 10mg
最小起訂量 1mg
發(fā)貨地 上海
更新日期 2024-12-12
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:化合物 CI-1040英文名稱:CI-1040
CAS:212631-79-3品牌: TargetMol
產(chǎn)地: 美國保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
純度規(guī)格: 99.1%產(chǎn)品類別: 抑制劑
貨號: T2443
2024-12-12 化合物 CI-1040 CI-1040 1mg/198RMB;5mg/443RMB;10mg/745RMB 198 TargetMol 美國 Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. 99.1% 抑制劑

Product Introduction

Bioactivity

名稱CI-1040
描述CI-1040 (PD 184352) (PD184352) is an ATP non-competitive MEK1/2 inhibitor (IC50: 17 nM).
細胞實驗Cells were planted seeded in T-75 cm2 flasks and treated the next day for 24 h with either DMSO or PD 184352. Single-cell suspensions were collected, and pellets were fixed in ice-cold ethanol (70%) for 30 min. After centrifugation of the samples, propidium iodide (50 μg/ml) and RNase (30 units/ml) were added to the pellets for 20 min at 37 °C. After filtration, samples were analyzed by flow cytometry [1].
激酶實驗All protein kinase activities were linear with respect to time in every incubation. Assays were performed either manually for 10 min at 30 °C in 50 μl incubations using [γ-32P]ATP, or with a Biomek 2000 Laboratory Automation Workstation in a 96-well format for 40 min at ambient temperature in 25 μl incubations using [γ-33P]ATP. The concentrations of ATP and magnesium acetate were 0.1 mM and 10 mM respectively, unless stated otherwise. This concentration of ATP is 5–10-fold higher than the Km for ATP of most of the protein kinases studied in the present paper, but lower than the normal intracellular concentration, which is in the millimolar range. All assays were initiated with MgATP. Manual assays were terminated by spotting aliquots of each incubation on to phosphocellulose paper, followed by immersion in 50 mM phosphoric acid. Robotic assays were terminated by the addition of 5 μl of 0.5 M phosphoric acid before spotting aliquots on to P30 filter mats. All papers were then washed four times in 50 mM phosphoric acid to remove ATP, once in acetone (manual incubations) or methanol (robotic incubations), and then dried and counted for radioactivity [2].
動物實驗Tumor fragments (approximately 3 mm^3 in size) were implanted subcutaneously into the right axillae of CD2F1 male mice (colon 26 studies) or female nude mice (HT-29 studies) 4–6 weeks old. Treatment was administered by gavage or intraperitoneally and was initiated either the day after tumor implantation (colon 26) or when tumors reached approximately 200 mg in size (HT-29). PD 184352 was prepared in a vehicle of 10% Cremophore EL, 10% ethanol and 80% water. Tumor size was evaluated periodically by caliper measurements, generally three times per week. Percent tumor growth inhibition was calculated as [(T–C)/number of days of treatment] × 100, with T and C being defined as the time required for treated and control tumors, respectively, to reach 750 mg (colon 26) or to reach twofold growth (HT-29) [1].
體外活性PD 184352(CI-1040)顯著降低了在血清存在條件下生長的多種腫瘤細胞系中磷酸化MAPK(pMAPK)的穩(wěn)態(tài)水平。在含1 μM PD 184352 的培養(yǎng)基中處理結(jié)腸26細胞1小時,可使pMAPK水平降低超過75%。用10 μM PD 184352處理結(jié)腸26細胞,不會抑制Jun激酶、p38激酶或AKT的磷酸化[1]。PD 184352抑制MKK1的IC50為0.3 μM,這比抑制Swiss 3T3細胞中EGF誘導(dǎo)的ERK2活化所需濃度高出15倍。在2 nM PD 184352 的作用下,MKK1在細胞中的活化被50%抑制[2]。CI-1040以劑量和時間依賴的方式誘導(dǎo)U-937細胞凋亡和抑制增殖。CI-1040顯著增加PUMA mRNA和蛋白水平。通過PUMA siRNA轉(zhuǎn)染敲低PUMA,可以抑制CI-1040誘導(dǎo)的U-937細胞凋亡和增殖抑制[3]。
體內(nèi)活性處理PD 184352(150 mg/kg,i.p. 或 p.o.)后1小時和6小時切除了腫瘤。無論通過何種給藥方式,PD 184352處理至少6小時內(nèi)完全抑制了MAPK磷酸化。MAPK磷酸化在給藥后12小時恢復(fù),并在24小時達到對照水平[1]。體內(nèi),MEK抑制劑CI-1040的系統(tǒng)給藥將腺瘤形成減少至三分之一,并顯著恢復(fù)了肺結(jié)構(gòu)。CL-1040處理的小鼠肺細胞的增殖率降低,對肺泡細胞的分化沒有明顯影響[4]。
存儲條件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度Ethanol : 12 mg/mL (25 mM)
DMSO : 47.9 mg/mL (100 mM)
關(guān)鍵字MEK | Inhibitor | MAP2K | Apoptosis | PD184352 | MAPKK | CI 1040 | PD-184352 | Mitogen-activated protein kinase kinase | CI1040 | inhibit | CI-1040
相關(guān)產(chǎn)品L-Glutamic acid | Metronidazole | 5-Fluorouracil | Dextran sulfate sodium salt (MW 4500-5500) | Stavudine | Tributyrin | Myricetin | Sorafenib | L-Ascorbic acid | Acetylcysteine | Salicylic acid | Sodium 4-phenylbutyrate
相關(guān)庫抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 激酶抑制劑庫 | 高選擇性抑制劑庫 | 藥物功能重定位化合物庫 | 酪氨酸激酶分子庫 | 疼痛相關(guān)化合物庫 | 抗癌臨床化合物庫 | 抗癌藥物庫
關(guān)鍵字: PD 184352|TargetMol

公司簡介

TargetMol Chemicals Inc. 總部位于馬薩諸塞州波士頓,致力于為全球生化領(lǐng)域科學(xué)家的研究提供專業(yè)的產(chǎn)品和服務(wù)。TargetMol?品牌的客戶群分布于40多個國家和地區(qū),已發(fā)展成為全球知名的化合物庫和小分子化合物研究供應(yīng)商。 TargetMol?可提供160多種滿足不同需求的化合物庫,以及多種類型的生化試劑產(chǎn)品,包括12000多種抑制劑、16000多種天然產(chǎn)物和各類多肽、抗體、生命科學(xué)試劑盒等,此外,我們還建設(shè)有CADD(計算機輔助藥物設(shè)計)研究中心、藥理實驗室、藥化合成平臺三大技術(shù)中心,全方位滿足客戶的定制需求。 憑借我們優(yōu)質(zhì)的產(chǎn)品和服務(wù)、快速高效的全球供應(yīng)鏈和專業(yè)的技術(shù)支持,我們將有效幫助您縮短研發(fā)周期,取得更成功的結(jié)果。
成立日期 2013-04-18 (12年) 注冊資本 566.265100萬人民幣
員工人數(shù) 100-500人 年營業(yè)額 ¥ 1億以上
主營行業(yè) 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) 經(jīng)營模式 貿(mào)易,工廠,試劑,定制,服務(wù)
  • TargetMol中國(陶術(shù)生物)
VIP 3年
  • 公司成立:12年
  • 注冊資本:566.265100萬人民幣
  • 企業(yè)類型:有限責(zé)任公司(自然人投資或控股)
  • 主營產(chǎn)品:小分子抑制劑、藥物篩選化合物庫、藥物篩選等
  • 公司地址:靜安區(qū)江場三路238號8樓
詢盤

化合物 CI-1040|T2443|TargetMol相關(guān)廠家報價

產(chǎn)品名稱 價格   公司名稱 報價日期
詢價
VIP3年
河南威梯?;た萍加邢薰?/div>
2024-12-25
詢價
VIP6年
上海澤葉生物科技有限公司
2024-12-25
¥1938.90
VIP1年
上海阿拉丁生化科技股份有限公司
2024-11-29
詢價
南京百鑫德諾生物科技有限公司
2024-09-26
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實性、準(zhǔn)確性和合法性由發(fā)布商家負責(zé)。 商家發(fā)布價格指該商品的參考價格,并非原價,該價格可能隨著市場變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價格,請咨詢商家,以實際成交價格為準(zhǔn)。請意識到互聯(lián)網(wǎng)交易中的風(fēng)險是客觀存在的